A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.

NCT06806995 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

PHA1A

Interventions

DRUG: Zidebactam-Cefepime
DRUG: Metronidazole
DRUG: FEP-ZID

Sponsor

Wockhardt

Collaborators

[object Object]